Publications

5808 Results

Evaluation of selenium supplementation on the prevention of bladder cancer in SWOG-coordinated SELECT

Authors
Y Lotan;P Goodman;R Youssef;R Svatek;S Shariat;C Tangen;IM Thompson;E Klein
Journal / Conference
Journal of Urology 187(6):2005-2010;
Year
2012
Research Committee(s)
Prevention, Screening, and and Surveillance
PMID
PMID22498220
PMC
PMC4294531
Study Number(s)
S0000

Prioritization in comparative effectiveness research: the CANCERGEN experience in cancer genomics

Authors
R Thariani;W Wong;J Carlson;L Garrison;SD Ramsey;P Deverka;L Esmail;S Rangarao;C Hoban;L Baker;D Veenstra
Journal / Conference
Medical Care 50(5):388-393;
Year
2012
Research Committee(s)
Breast
PMID
PMID22274803
PMC
PMC3469160
Study Number(s)
S1007

Cetuximab plus cisplatin, irinotecan, and thoracic radiotherapy as definitive treatment for locally advanced, unresectable esophageal cancer: a phase II study of the SWOG (S0414)

Authors
M Tomblyn;B Goldman;C Thomas;J Benedetti;H Lenz;V Mehta;T Beeker;P Gold;J Abbruzzese;C Blanke
Journal / Conference
Journal of Thoracic Oncology 7(5):906-992;
Year
2012
Research Committee(s)
Gastrointestinal
PMID
PMID22481235
PMC
PMC3382003
Study Number(s)
S0414

A phase II trial of doxorubicin and gemcitabine in renal cell carcinoma with sarcomatoid features: ECOG 8802

Authors
NB Haas;X Lin;J Manola;M Pins;G Liu;D Mcdermott;D Nanus;E Heath;G Wilding;J Dutcher
Journal / Conference
Medical Oncology 29(2):761-767
Year
2012
Research Committee(s)
Genitourinary
PMID
PMID21298497
PMC
PMC3566570
Study Number(s)
CTSU/E8802

Phase I and randomized phase II trial of gemcitabine, erlotinib, and IMC-A12 (cixutumumab) versus gemcitabine plus erlotinib as first line treatment in patients with metastatic pancreatic cancer (SWOG-0727)

Authors
PA Philip;B Goldman;R Ramanathan;HJ Lenz;A Lowy;RP Whitehead;S Iqbal;R Gaur;J Benedetti;CD Blanke
Journal / Conference
Journal of Clinical Oncology 30(suppl 4; abstr 198); ASCO 2012 GI Cancers Symposium, poster;
Year
2012
Research Committee(s)
Gastrointestinal
Study Number(s)
S0727

Use of EGF A61G polymorphism predicts overall survival in a phase III study of gemcitabine plus cetuximab versus gemcitabine in patients (pts) with locally advanced or metastatic pancreatic adenocarcinoma (SWOG 0205)

Authors
J Labonte;B Goldman;Wu Zhang;M Labonte;C Blanke;P Philip;R Wong;E O'Reilly;J Benedetti;HJ Lenz
Journal / Conference
Journal of Clinical Oncology 30(supl 4; abstr 203); ASCO 2012 GI Cancers Symposium, poster presentation;
Year
2012
Research Committee(s)
Gastrointestinal
Study Number(s)
S0205

Randomized phase II trial of sorafenib with temsirolimus or tipifarnib in untreated metastatic melanoma (SWOG S0438) [PMID:22228638; PMC3481165; NIHMSID410808;]

Authors
K Margolin;J Moon;L Flaherty;C Lao;C Lao;M Othus;JA Sosman;J Kirkwood;V Sondak
Journal / Conference
Clinical Cancer Research 18(4):1129-1137;
Year
2012
Research Committee(s)
Melanoma
PMID
PMID22228638
PMC
PMC3481165
Study Number(s)
S0438

Impact of residual normal metaphases in core binding factor acute myeloid leukemia

Authors
B Medeiros;M Othus;M Fang;F Appelbaum;E Estey
Journal / Conference
Cancer 118(9):2420-2423;
Year
2012
Research Committee(s)
Leukemia
PMID
PMID21928314
PMC
PMC3490403
Study Number(s)
S0106, S0112, SWOG-8600, SWOG-9031, SWOG-9034 (EST-3489) (CALGB-9120), SWOG-9126, SWOG-9333, SWOG-9500, S9617, S9910, S9918

Tumor-associated macrophages predict inferior outcomes in locally advanced and advanced stage classical Hodgkins lymphoma - a correlative study from the E2496 intergroup trial http://www.abstracts2view.com/uscap12/view.php?nu=USCAP12L_1568

Authors
KL Tan;DW Scott;F Hong;SJ Horning;RI Fisher;N Bartlett;L Shepherd;JM Connors;BS Kahl;LI Gordon;C Steidl;R Gascoyne
Journal / Conference
United States and Canadian Academy of Pathology, abst. #1568; poster presentation;
Year
2012
Research Committee(s)
Lymphoma
Study Number(s)
E2496

Patient reported cognitive impairments among women with breast cancer randomized to hormonal therapy alone versus chemotherapy followed by hormonal therapy: results from the TAILORx trial (PACCT-1)

Authors
L Wagner;R Gray;G Sledge;T Whelan;J Zujewski;DF Hayes;CE Geyer;EC Dees;J Sparano
Journal / Conference
International Cognition and Cancer Taskforce, 2012 meeting, poster;
Year
2012
Research Committee(s)
Breast